TGFB1 and neoplasm: Importantly, both inhibition assays for TGF‐β1 and p‐Erk result in significantly decreasing the proliferation and migration of OSCC cells in vitro (Figure S2), and significantly decreasing tumour size compared with the control group in vivo (Figure 6).